NM_031283.3:c.142G>C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031283.3(TCF7L1):c.142G>C(p.Glu48Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000536 in 1,492,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031283.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151890Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000383 AC: 4AN: 104458Hom.: 0 AF XY: 0.0000355 AC XY: 2AN XY: 56270
GnomAD4 exome AF: 0.00000448 AC: 6AN: 1340088Hom.: 0 Cov.: 33 AF XY: 0.00000607 AC XY: 4AN XY: 659298
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152008Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.142G>C (p.E48Q) alteration is located in exon 1 (coding exon 1) of the TCF7L1 gene. This alteration results from a G to C substitution at nucleotide position 142, causing the glutamic acid (E) at amino acid position 48 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at